GlassScriptPhysician profile
Cheryl D Athey
NPI 1801216726
$1,720.04
in general payments reported to CMS, 2019-2025
26 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $745 · 2023: $426 · 2024: $181 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $224.31 | 2022-2023 | Aveed, Xiaflex, Edex |
| Organon LLC | $193.92 | 2024-2025 | Nexplanon |
| 180 Medical, INC. | $182.91 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $147.05 | 2023 | Gemtesa |
| Myovant Sciences INC. | $129.94 | 2021-2022 | |
| Gilead Sciences, INC. | $127.67 | 2025 | |
| Pfizer INC. | $118.60 | 2022 | |
| Convatec INC. | $107.20 | 2022 | |
| Exeltis, USA INC. | $58.03 | 2023-2025 | Slynd |
| Astellas Pharma US INC | $55.80 | 2023-2024 | Veozah, Myrbetriq |
| Urovant Sciences INC | $52.52 | 2022 | |
| Boston Scientific Corporation | $33.08 | 2022-2023 | Spaceoar Vue System - 10ml |
| Medtronic, INC. | $32.27 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $29.48 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.31 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $23.93 | 2025 | |
| Teleflex LLC | $23.08 | 2022 | |
| Janssen Biotech, INC. | $22.52 | 2024 | Erleada, Akeega |
| Amgen INC. | $18.96 | 2021 | |
| Progenics Pharmaceuticals, INC. | $18.69 | 2022 | |
| Viiv Healthcare Company | $18.56 | 2025 | Apretude |
| Novo Nordisk INC | $17.17 | 2021 | |
| Procept Biorobotics Corporation | $16.24 | 2023 | Aquabeam Robotic System |
| Takeda Pharmaceuticals U.S.A., INC. | $16.03 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.42 | 2022 | |
| Coloplast Corp | $13.35 | 2023 | Speedicath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Athey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.